Cys2,7EtαCGRP is a potent agonist for CGRP1 receptors in SK-N-MC cells

Biochemical Pharmacology

Volumn 69, Issue 8, 2005, Pages 1235-1240

  Nodin, Christina ^a,c   Vauquelin, Georges ^b   Von Mentzer, Bengt ^a  

^a ASTRAZENECA R AND D   (Sweden)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Calcitonin gene related peptide; CGRP receptor subtypes; CGRP (8 37); Cys2,7Et calcitonin gene related peptide; Receptor activity modifying protein

Indexed keywords

ALPHA CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE[8-37]; CYCLIC AMP; CYSTEINE 2,7 ETHYLAMIDE ALPHA CALCITONIN GENE RELATED PEPTIDE; IODINE 125; UNCLASSIFIED DRUG; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE (8 37); CALCITONIN GENE-RELATED PEPTIDE (8-37); DIAGNOSTIC AGENT; LIGAND; PEPTIDE FRAGMENT; RADIOACTIVE IODINE;

ARTICLE; BINDING SITE; CELL MEMBRANE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; STIMULATION; BINDING COMPETITION; BIOSYNTHESIS; COMPARATIVE STUDY; DOSE RESPONSE; DRUG POTENTIATION; KINETICS; METABOLISM; NEUROBLASTOMA; TUMOR CELL LINE;

BINDING SITES; BINDING, COMPETITIVE; CALCITONIN GENE-RELATED PEPTIDE; CELL LINE, TUMOR; CELL MEMBRANE; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IODINE RADIOISOTOPES; KINETICS; LIGANDS; NEUROBLASTOMA; PEPTIDE FRAGMENTS; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE;

EID: 18044379918     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.01.008     Document Type: Article

References (35)

1. S.G. Amara, V. Jonas, M.G. Rosenfeld, E.S. Ong, and R.M. Evans Alternative RNA processing in calcitonin gene expression generates mRNA's encoding different polypeptide products Nature 298 1982 240 244
2. S.D. Brain, and H. Cambridge Calcitonin gene-related peptide: vasoactive effects and potential therapeutic role Gen Pharmacol 274 1996 607 611
3. T. Dennis, A. Fournier, S. St Pierre, and R. Quirion Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues Evidence for receptor multiplicity J Pharmacol Exp Ther 251 1989 718 725
4. D.R. Poyner Pharmacology of receptors for calcitonin gene-related peptide and amylin TIPS 16 1995 424 428
5. C. Juaneda, Y. Dumont, and R. Quirion The molecular pharmacology of CGRP and related peptide receptor subtypes Trends Pharmacol Sci 21 2000 432 438
6. T. Dennis, A. Fournier, A. Cadieux, F. Pomerleau, F.B. Jolicoeur, and S. St-Pierre hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery J Pharmacol Exp Ther 254 1990 123 128
7. Y. Dumont, A. Fournier, S. St-Pierre, and R. Quirion A potent and selective CGRP2 agonist, [Cys(Et)27]hCGRP alpha: comparison in prototypical CGRP1 and CGRP2 in vitro bioassays Can J Physiol Pharmacol 75 1997 671 676
8. C.A. Maggi, T. Chiba, and S. Guiliani Human-calcitonin gene-related peptide (8-37) as an antagonist of exogenous and endogenous calcitonin gene-related peptide Eur J Pharmacol 192 1991 85 88
9. M. Mimeault, A. Fournier, Y. Dumont, S. St-Pierre, and R. Quirion Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery J Pharmacol Exp Ther 258 1991 1084 1090
10. 125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues J Pharmacol Exp Ther 269 1994 846 853
11. D.R. Poyner, G.M. Taylor, A.E. Tomlinson, A.G. Richardson, and D.M. Smith Characterization of receptors for calcitonin gene-related peptide and adrenomedullin on the guinea-pig vas deferens Br J Pharmacol 125 1999 1276 1282
12. J. Longmore, J.E. Hogg, P.H. Hutson, and R.G. Hill Effects of two truncated forms of human calcitonin-gene-related peptide: implications for receptor classification Eur J Pharmacol 265 1994 53 59
13. Waugh DJJ, C.S. Bockman, D.D. Smith, and P.W. Abel Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors J Pharmacol Exp Ther 289 1999 1419 1426
14. M. Morfis, A. Christopoulos, and P.M. Sexton RAMPs: 5 years on, where to now? Trends Pharmacol Scidkjdot 24 2003 596 601
15. S.M. Foord, and L.M. McLatchie RAMPs: accessory proteins for seven transmembrane domain receptors Trends Pharmacol Sci 20 2003 184 186
16. D.L. Hay, S.G. Howitt, A.C. Conner, M. Schindler, D.M. Smith, and D.R. Poyner CL/Ramp2 and CL/Ramp3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin 22-52, CGRP 8-37 and BIBN4096BS Br J Pharmacol 140 2003 477 486
17. D.R. Poyner, U. Soomets, S.G. Howitt, and U. Langel Structural determinants for binding to CGRP receptors expressed by human SK-N-MC and Col 29 cells: studies with chimeric and other peptides Br J Pharmacol 124 1998 1659 1666
18. T. Choksi, D.L. Hay, L. Legon, D.R. Poyner, S. Hagne, and S.R. Bloom Comaprison of the expression of calcitonin receptor like receptor (CLRL) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines Br J Pharmacol 136 2002 784 792
19. H. Schild Pax and competitive drug antagonism Br J Pharmacol 4 1949 277 280
20. H. Doods, G. Hallermayer, D. Wu, M. Entzeroth, K. Rudolf, and W. Engel Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist Br J Pharmacol 129 2000 420 423
21. D.L. Hay, S.G. Howitt, A.C. Conner, H. Doods, M. Schindler, and D.R. Poyner A comparision of the action of BIBN4096BS and CGRP8-37 on CGRP and adrenomedulin receptors expressed on SK-N-MC, L6 Col 29 and Rat 2 cells Br J Pharmacol 137 2002 80 86
22. 3H]BIBN4096BS Eur J Pharmacol 442 2002 187 193
23. Kenakin TP. Competitive antagonism, in pharmacologic analysis of drug-receptor interaction. New York: Raven Press; 1993. p. 278-322.
24. C. Tortorella, C. Macchi, M. Forneris, and G.G. Nussdorfer Calcitonin gene-related peptide (CGRP), acting via CGRP type 1 receptors, inhibits potassium-stimulated aldosterone secretion and enhances basal catecholamine secretion from rat adrenal gland Int J Mol Med 8 2001 261 264
25. L. Edvinsson, A. Sams, I. Jansen-Olesen, J. Tajti, S.A. Kane, and R.Z. Rutledge Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries Eur J Pharmacol 415 2001 39 44
26. J.J. Mallee, C.A. Salvatore, B. Lebourdelles, K.R. Oliver, J. Longmore, and K. Koblan Ramp1 determines the species selectivity of non-peptide CGRP receptor antagonists J Biol Chem 277 2002 14294 14298
27. T. Kenakin The classification of seven transmembrane receptors in recombinant expression systems Pharmacol Rev 48 1996 413 463
28. A.C. Holloway, H. Qian, L. Pipolo, J. Ziogas, S. Miura, and S. Karnik Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors Mol Pharmacol 61 2002 768 777
29. T. Kenakin Agonist-receptor efficacy: II. Agonist trafficking of receptor signals Trends Pharmacol Sci 16 1995 232 238
30. E. Hermans Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors Pharmacol Ther 99 2003 25 44
31. T. Chiba, A. Yamaguchi, T. Yamatani, A. Nakamura, T. Morishita, and T. Inui Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37) Am J Physiol 256 1989 E331 E335
32. L.J. Pike Lipid rafts: bringing order to chaos J Lipid Res 44 2003 655 667
33. 27 hCGRP-preferring receptor Eur J Pharmacol 400 2000 313 319
34. T. Kenakin Principles: receptor theory in pharmacology Trends Pharmacol Sci 25 2004 186 192
35. 50) of an enzymatic reaction Biochem Pharmacol 22 1973 3099 3108